| 1 |
Investigation for GSK3 beta expression in diabetic osteoporosis and negative osteogenic effects of GSK3 beta on bone marrow mesenchymal stem cells under a high glucose microenvironment
Chen Y, Chen L, Huang RY, Yang WY, Chen SY, Lin KL, Liu JQ
Biochemical and Biophysical Research Communications, 534, 727, 2021 |
| 2 |
Cereblon (CRBN) deletion reverses streptozotocin induced diabetic osteoporosis in mice
Yao C, Guo X, Yao WX, Zhang C
Biochemical and Biophysical Research Communications, 496(3), 967, 2018 |
| 3 |
MiR-449 overexpression inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via suppressing Sirt1/Fra-1 pathway in high glucose and free fatty acids microenvironment
Qu B, Gong K, Yang HS, Li YG, Jiang T, Zeng ZM, Cao ZR, Pan XM
Biochemical and Biophysical Research Communications, 496(1), 120, 2018 |
| 4 |
High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway
Cai ZY, Yang B, Shi YX, Zhang WL, Liu F, Zhao W, Yang MW
Biochemical and Biophysical Research Communications, 503(2), 428, 2018 |
| 5 |
MiR-132 regulates osteogenic differentiation via downregulating Sirtuin1 in a peroxisome proliferator-activated receptor beta/delta-dependent manner
Gong K, Qu B, Liao DF, Liu D, Wang CR, Zhou JS, Pan XM
Biochemical and Biophysical Research Communications, 478(1), 260, 2016 |
